Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8710227
APP PUB NO 20130183380A1
SERIAL NO

13698759

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FORUM PHARMACEUTICALS INC500 ARSENAL STREET WATERTOWN MA 02472

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chesworth, Richard Boston, US 171 3995
Ishige, Takayuki Osaka, JP 12 21
Kishida, Muneki Osaka, JP 13 9
Oliver-Shaffer, Patricia Acton, US 8 48
Shapiro, Gideon Gainesville, US 125 2170

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 29, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00